Informationen:
Fehler:
ID
14599
Beschreibung
Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00494091
Link
https://clinicaltrials.gov/show/NCT00494091
Stichworte
Versionen (1)
- 23.04.16 23.04.16 -
Hochgeladen am
23. April 2016
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Advanced Renal Cell Carcinoma NCT00494091
Eligibility Advanced Renal Cell Carcinoma NCT00494091
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Advanced Renal Cell Carcinoma NCT00494091
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Renal Cell Carcinoma
Item
subjects with histologically confirmed, advanced (stage iv or recurrent disease) rcc. the american joint committee on cancer (ajcc) staging and classification criteria will be used.
boolean
C0007134 (UMLS CUI [1])
ecog performance status
Item
ecog performance status of 0-1.
boolean
C1520224 (UMLS CUI [1])
recist
Item
at least one measurable lesion per recist.
boolean
C1709926 (UMLS CUI [1])
age
Item
age greater than or equal to 20 years.
boolean
C0001779 (UMLS CUI [1])
Asiens
Item
japanese, chinese, or korean ethnicity.
boolean
C0078988 (UMLS CUI [1])
cns metastases
Item
cns metastases at screening or history or cns metastases.
boolean
chemotherapeutic, cytokine-based, or other investigational agents
Item
prior targeted, chemotherapeutic, cytokine-based, or other investigational agents for the treatment of rcc within 4 weeks before first dose of test article. subjects must have documented objective progressive disease after any prior systemic rcc treatment and have recovered to grade 1 or lower toxicities from effects of prior systemic therapy for rcc.
boolean
C1514457 (UMLS CUI [1])
Malignant Neoplasms
Item
in past 5 years, other prior malignancy (except basal cell carcinoma, squamous cell carcinoma of the skin, or cervical carcinoma in situ).
boolean
C0006826 (UMLS CUI [1])